{"title":"解读《中国失眠障碍诊疗指南》","authors":"Shuai Liu, Bin Zhang","doi":"10.3969/cjcnn.v17i9.1653","DOIUrl":null,"url":null,"abstract":"In June 2016, in order to provide a standardized clinical reference for the diagnosis and treatment of insomnia, \"Guidelines for the diagnosis and treatment of insomnia disorder in China\" compiled by Chinese Sleep Research Society (CSRS) was published. The guideline was compiled according to the standards of evidence-based medicine and the latest International Classification of Sleep Disorders Third Edition (ICSD - 3). It emphasized the role of cognitive behavioral treatment (CBT) in the treatment of insomnia, and enriched the assessment and interventions for special populations. This paper intends to provide an explanation and supplement to the compiling process and key elements of the guideline in details, in order to offer some help and guidance for clinicians for better understanding and application of the guideline. DOI: 10.3969/j.issn.1672-6731.2017.09.002","PeriodicalId":10113,"journal":{"name":"中国现代神经疾病杂志","volume":"17 1","pages":"633-638"},"PeriodicalIF":0.0000,"publicationDate":"2017-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"Interpretation of \\\"Guidelines for the diagnosis and treatment of insomnia disorder in China\\\"\",\"authors\":\"Shuai Liu, Bin Zhang\",\"doi\":\"10.3969/cjcnn.v17i9.1653\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In June 2016, in order to provide a standardized clinical reference for the diagnosis and treatment of insomnia, \\\"Guidelines for the diagnosis and treatment of insomnia disorder in China\\\" compiled by Chinese Sleep Research Society (CSRS) was published. The guideline was compiled according to the standards of evidence-based medicine and the latest International Classification of Sleep Disorders Third Edition (ICSD - 3). It emphasized the role of cognitive behavioral treatment (CBT) in the treatment of insomnia, and enriched the assessment and interventions for special populations. This paper intends to provide an explanation and supplement to the compiling process and key elements of the guideline in details, in order to offer some help and guidance for clinicians for better understanding and application of the guideline. DOI: 10.3969/j.issn.1672-6731.2017.09.002\",\"PeriodicalId\":10113,\"journal\":{\"name\":\"中国现代神经疾病杂志\",\"volume\":\"17 1\",\"pages\":\"633-638\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国现代神经疾病杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3969/cjcnn.v17i9.1653\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国现代神经疾病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3969/cjcnn.v17i9.1653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Interpretation of "Guidelines for the diagnosis and treatment of insomnia disorder in China"
In June 2016, in order to provide a standardized clinical reference for the diagnosis and treatment of insomnia, "Guidelines for the diagnosis and treatment of insomnia disorder in China" compiled by Chinese Sleep Research Society (CSRS) was published. The guideline was compiled according to the standards of evidence-based medicine and the latest International Classification of Sleep Disorders Third Edition (ICSD - 3). It emphasized the role of cognitive behavioral treatment (CBT) in the treatment of insomnia, and enriched the assessment and interventions for special populations. This paper intends to provide an explanation and supplement to the compiling process and key elements of the guideline in details, in order to offer some help and guidance for clinicians for better understanding and application of the guideline. DOI: 10.3969/j.issn.1672-6731.2017.09.002